General Catalyst Group Management’s Oscar Health OSCR Stock Holding History

General Catalyst Group Management’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,107,719	Closed	-$45.2M	–	9
2025 Q2	$45.2M	Hold	2,107,719	–	–	1.05%	3
2025 Q1	$27.6M	Hold	2,107,719	–	–	3.11%	7
2024 Q4	$28.3M	Hold	2,107,719	–	–	2.48%	8
2024 Q3	$44.7M	Hold	2,107,719	–	–	3.12%	4
2024 Q2	$33.3M	Hold	2,107,719	–	–	2.87%	4
2024 Q1	$31.3M	Hold	2,107,719	–	–	2.41%	6
2023 Q4	$19.3M	Sell	2,107,719 -4,576,137	-68%	-$31.6M	1.52%	6
2023 Q3	$37.2M	Sell	6,683,856 -4,281,139	-39%	-$30M	3.54%	5
2023 Q2	$88.4M	Sell	10,964,995 -3,500,000	-24%	-$25.8M	7.07%	2
2023 Q1	$94.6M	Hold	14,464,995	–	–	9.8%	2
2022 Q4	$35.6M	Hold	14,464,995	–	–	4%	4
2022 Q3	$72.2M	Hold	14,464,995	–	–	6.65%	5
2022 Q2	$61.5M	Hold	14,464,995	–	–	5.48%	5
2022 Q1	$144M	Hold	14,464,995	–	–	8.19%	4
2021 Q4	$114M	Hold	14,464,995	–	–	4.32%	6
2021 Q3	$252M	Hold	14,464,995	–	–	12.8%	4
2021 Q2	$311M	Hold	14,464,995	–	–	13.45%	3
2021 Q1	$389M	Buy	+14,464,995	New	+$453M	15.03%	2

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

General Catalyst Group Management's OSCR Position: Q3 2025 in Review

General Catalyst Group Management sold out of Oscar Health (OSCR) in Q3 2025, closing a stake of 2,107,719 shares — an estimated $45.2M sold.

General Catalyst Group Management first reported a position in OSCR in Q1 2021 and held it in 18 quarters. The position peaked at $389M in Q1 2021. 343 funds tracked by Wall St. Rank hold OSCR as of Q3 2025.

General Catalyst Group Management reported no remaining Oscar Health position as of Q3 2025 after selling out during the quarter.
General Catalyst Group Management sold 2,107,719 Oscar Health shares in Q3 2025, an estimated $45.2M.
General Catalyst Group Management first reported a position in Oscar Health in Q1 2021 and held it in 18 quarters.
General Catalyst Group Management's Oscar Health position peaked at $389M in Q1 2021.
343 funds tracked by Wall St. Rank held Oscar Health as of Q3 2025.

Based on General Catalyst Group Management's 13F filing for Q3 2025, filed 14 Nov 2025.